We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Analysis of Immune Responses in Patients Treated With Vacc-4x Supports Further Development

News   Sep 12, 2012

 
Analysis of Immune Responses in Patients Treated With Vacc-4x Supports Further Development
 
 
 

RELATED ARTICLES

Is it Flu or Just a Cold?

News

Most people struggle to distinguish between influenza, "real" flu, and the common cold and this often leads to irritation and the perpetuation of myths.

READ MORE

Resistant Melanoma Sensitized to Cytotoxic T Cells with BRAF-targeting

News

BRAF-targeted therapies render resistant melanoma more sensitive to the attack of killer T cells. The findings pave the way in developing therapy for patients that have become resistant to BRAF inhibitors.

READ MORE

Drug Combo Could Become New Standard Treatment for Advanced Kidney Cancer

News

A combination of two drugs – one of them an immunotherapy agent – could become a new standard, first-line treatment for patients with metastatic kidney cancer, says an investigator from Dana-Farber Cancer Institute, reporting results from a Phase 3 clinical trial.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE